News from Catabasis Pharmaceuticals, Inc. A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages.

Latest

Dec 05, 2013, 08:00 ET Catabasis Initiates Phase 2 Trial of CAT-2003 in Patients with Severe Hypertriglyceridemia

 Catabasis Pharmaceuticals, Inc., today announced the initiation of a Phase 2 clinical trial investigating the safety and efficacy of CAT-2003...


Nov 15, 2013, 00:01 ET Catabasis Closes $32.4 Million Series B Financing

 Catabasis Pharmaceuticals, Inc., today announced it has completed a $32.4 million Series B financing round led by new investor Lightstone...


Nov 13, 2013, 08:00 ET Catabasis Names Ian Sanderson Chief Financial Officer

Catabasis Pharmaceuticals, Inc., today announced that it has named Ian Sanderson its chief financial officer. Mr. Sanderson brings to Catabasis...


Aug 28, 2013, 08:00 ET Catabasis to Present Phase 1 Data from Oral SMART Linker Conjugate CAT-2003 at Upcoming Conference

Catabasis Pharmaceuticals, Inc., today announced that new clinical data on the inhibition of PCSK9* by its oral SMART Linker conjugate, CAT-2003,...


Jul 30, 2013, 08:00 ET Catabasis' CAT-2003 Demonstrates Significant Reduction of Fasting and Post-Prandial Triglycerides in Successful Phase 1 Trial

 Catabasis Pharmaceuticals, Inc., today announced that preliminary data from a Phase 1 trial of CAT-2003, an oral SMART Linker conjugate...


Feb 11, 2013, 08:00 ET Catabasis Announces Positive Phase 1 Data for CAT-1004 Validating the SMART Linker Technology Platform

 Catabasis Pharmaceuticals, Inc., today announced that a three-part series of Phase 1 studies showed that CAT-1004, a SMART Linker conjugate of...